{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:17:57Z","timestamp":1789676277381,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009712","name":"Dravet Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.yebeh.2014.12.028","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T17:46:36Z","timestamp":1423244796000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Luis Miguel","family":"Aras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mingorance-Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.12.028_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2014.12.028_bb0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/epi.12626","article-title":"Terminology and prognosis of Dravet syndrome","volume":"55","author":"Dravet","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2014.12.028_bb0015","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ejpn.2012.04.007","article-title":"Diagnosis and long-term course of Dravet syndrome","volume":"16","author":"Scheffer","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.12.028_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2011.02997.x","article-title":"The genetics of Dravet syndrome","volume":"52","author":"Marini","year":"2011","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2014.12.028_bb0025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1528-1167.2012.03516.x","article-title":"Targeted next generation sequencing as a diagnostic tool in epileptic disorders","volume":"53","author":"Lemke","year":"2012","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2014.12.028_bb0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.yebeh.2014.12.028_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/humu.10217","article-title":"De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy","volume":"21","author":"Claes","year":"2003","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.yebeh.2014.12.028_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0883073813509016","article-title":"Broad phenotypic heterogeneity due to a novel SCN1A mutation in a family with genetic epilepsy with febrile seizures plus","volume":"29","author":"Goldberg-Stern","year":"2014","journal-title":"J Child Neurol"},{"issue":"7397","key":"10.1016\/j.yebeh.2014.12.028_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":"Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations","volume":"485","author":"O'Roak","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yebeh.2014.12.028_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0883073812443309","article-title":"SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache","volume":"28","author":"Frosk","year":"2013","journal-title":"J Child Neurol"},{"issue":"34","key":"10.1016\/j.yebeh.2014.12.028_bb0055","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1523\/JNEUROSCI.2475-09.2009","article-title":"A functional null mutation of SCN1B in a patient with Dravet syndrome","volume":"29","author":"Patino","year":"2009","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.yebeh.2014.12.028_bb0060","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.braindev.2009.08.009","article-title":"Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome","volume":"31","author":"Shi","year":"2009","journal-title":"Brain Dev"},{"issue":"3","key":"10.1016\/j.yebeh.2014.12.028_bb0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eplepsyres.2013.12.005","article-title":"Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy","volume":"108","author":"Ishii","year":"2014","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2014.12.028_bb0070","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajhg.2013.09.017","article-title":"De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome","volume":"93","author":"Suls","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.yebeh.2014.12.028_bb0075","doi-asserted-by":"crossref","first-page":"e1000381","DOI":"10.1371\/journal.pgen.1000381","article-title":"Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females","volume":"5","author":"Depienne","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.yebeh.2014.12.028_bb0080","article-title":"SCN1A genetic test for Dravet syndrome (severe myoclonic epilepsy of infancy and its clinical subtypes) for use in the diagnosis, prognosis, treatment and management of Dravet syndrome","volume":"5","author":"Stenhouse","year":"2013","journal-title":"PLoS Curr"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.12.028_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome","volume":"52","author":"Chiron","year":"2011","journal-title":"Epilepsia"},{"issue":"9242","key":"10.1016\/j.yebeh.2014.12.028_bb0090","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.yebeh.2014.12.028_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2006.10.001","article-title":"Stiripentol","volume":"4","author":"Chiron","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"Pt 8","key":"10.1016\/j.yebeh.2014.12.028_bb0100","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/aws151","article-title":"Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome","volume":"135","author":"Brunklaus","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.12.028_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1750-1172-8-176","article-title":"Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy","volume":"8","author":"Nabbout","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.yebeh.2014.12.028_bb0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1528-1167.2010.02925.x","article-title":"Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients","volume":"52","author":"Ragona","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2014.12.028_bb0115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/epi.12762","article-title":"Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24months in 347 children","volume":"55","author":"Orosz","year":"2014","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2014.12.028_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40263-013-0041-6","article-title":"Treatment of epileptic encephalopathies","volume":"27","author":"McTague","year":"2013","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.yebeh.2014.12.028_bb0125","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0883073813487599","article-title":"The ketogenic diet in Dravet syndrome","volume":"28","author":"Laux","year":"2013","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2014.12.028_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000265222.24102.db","article-title":"An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy","volume":"69","author":"Striano","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.12.028_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-8749.2011.03967.x","article-title":"Current therapeutic procedures in Dravet syndrome","volume":"53","author":"Chiron","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2014.12.028_bb0140","first-page":"S2","article-title":"Antiepileptic drug-induced worsening of seizures in children","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014006982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014006982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:24:00Z","timestamp":1761503040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014006982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":28,"alternative-id":["S1525505014006982"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.12.028","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}